Psychedelic-enhanced psychotherapy is gaining traction in response to clinical research and academic studies showing compelling evidence in addressing the growing mental health crisis globally.

The first to take an integrated approach to psychedelic medicine, Field Trip Health Ltd. is positioned to be the leader by leveraging anonymous patient data from their network of Field Trip Health clinics and digital tools to inform a proprietary, competitive drug development pipeline designed for the best patient outcomes.

The entrepreneurial management team has one of the top track records for establishing and growing medical clinics in the similarly highly-regulated industry of cannabis, and are well-positioned to leverage the trend toward psychedelic-enhanced therapies.

Successful closings of two external financings have brought in approximately $24 million to fund growth and propel Field Trip forward in the mission to bringing people to life through psychedelic therapies.